Martin Toal
Impact in
- Pathology and Forensic Medicine top 0.5%
- Multiple Sclerosis Research Studies
- Neurology top 2%
- Peripheral Neuropathies and Disorders
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Acute Myeloid Leukemia Research 3
-
- Adenosine and Purinergic Signaling 1
- Co-authors
- Ludwig KapposDavid H. MillerFrances LynnFred LublinEva HavrdováGavin GiovannoniA WajgtMichael Panzara
- Journals
- Irish Journal of Psychological Medicine (1 paper)Clinical Cancer Research (1 paper)British Journal of Haematology (1 paper)New England Journal of Medicine (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Martin Toal
9 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Pathology and Forensic Medicine 1.9k
- Neurology 600
- Oncology 977
- Immunology 685
- Rheumatology 417
Countries citing papers authored by Martin Toal
This map shows the geographic impact of Martin Toal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Toal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Toal more than expected).
Fields of papers citing papers by Martin Toal
This network shows the impact of papers produced by Martin Toal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Toal. The network helps show where Martin Toal may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Toal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2013 | 34 | |
| 3 | 2013 | 34 | |
| 4 | 2012 | 64 | |
| 5 | 2011 | 1 | |
| 6 | A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis Hit paper breakdown → | 2006 | 2413 |
| 7 | 2005 | 54 | |
| 8 | 2000 | 9 | |
| 9 | 1994 | 2 |
About Martin Toal
Martin Toal is a scholar working on Hematology, Physiology, Oncology, Pathology and Forensic Medicine and Genetics, having authored 9 papers that have together received 2.6k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (4 papers), Acute Myeloid Leukemia Research (3 papers), Peptidase Inhibition and Analysis (2 papers), Multiple Sclerosis Research Studies (2 papers), Blood disorders and treatments (2 papers), Adenosine and Purinergic Signaling (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.9k citations), Neurology (600 citations), Oncology (977 citations), Immunology (685 citations) and Rheumatology (417 citations). Martin Toal has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Ludwig Kappos, David H. Miller, Frances Lynn, Fred Lublin, Eva Havrdová, Gavin Giovannoni, A Wajgt, Michael Panzara, Alfred Sandrock and Chris H. Polman. Their work appears in journals such as Irish Journal of Psychological Medicine, Clinical Cancer Research, British Journal of Haematology, New England Journal of Medicine and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.